PubRank

In-San Kim

Author PubWeight™ 134.47‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The 5p15.33 locus is associated with risk of lung adenocarcinoma in never-smoking females in Asia. PLoS Genet 2010 1.90
2 Identification of motifs in the fasciclin domains of the transforming growth factor-beta-induced matrix protein betaig-h3 that interact with the alphavbeta5 integrin. J Biol Chem 2002 1.53
3 TGFBIp/betaig-h3 protein: a versatile matrix molecule induced by TGF-beta. Int J Biochem Cell Biol 2007 1.51
4 Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles. J Control Release 2008 1.44
5 Transforming growth factor-beta-induced protein (TGFBIp/beta ig-h3) activates platelets and promotes thrombogenesis. Blood 2009 1.42
6 Targeting prion-like protein doppel selectively suppresses tumor angiogenesis. J Clin Invest 2016 1.39
7 Betaig-h3 supports keratinocyte adhesion, migration, and proliferation through alpha3beta1 integrin. Biochem Biophys Res Commun 2002 1.38
8 Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy. J Control Release 2008 1.38
9 Tumor-homing multifunctional nanoparticles for cancer theragnosis: Simultaneous diagnosis, drug delivery, and therapeutic monitoring. J Control Release 2010 1.37
10 DNMT3B polymorphisms and risk of primary lung cancer. Carcinogenesis 2004 1.37
11 Tetraspanin TM4SF5 mediates loss of contact inhibition through epithelial-mesenchymal transition in human hepatocarcinoma. J Clin Invest 2008 1.35
12 Biodistribution and anti-tumor efficacy of doxorubicin loaded glycol-chitosan nanoaggregates by EPR effect. J Control Release 2003 1.34
13 Cell-permeable and biocompatible polymeric nanoparticles for apoptosis imaging. J Am Chem Soc 2006 1.33
14 Self-assembled nanoparticles based on glycol chitosan bearing hydrophobic moieties as carriers for doxorubicin: in vivo biodistribution and anti-tumor activity. Biomaterials 2006 1.32
15 Identification of the alphavbeta3 integrin-interacting motif of betaig-h3 and its anti-angiogenic effect. J Biol Chem 2003 1.31
16 Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice. J Control Release 2007 1.29
17 Vascular endothelial growth factor gene polymorphisms and risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev 2005 1.29
18 Beta ig-h3 promotes renal proximal tubular epithelial cell adhesion, migration and proliferation through the interaction with alpha3beta1 integrin. Exp Mol Med 2004 1.23
19 Polymorphisms in the survivin gene and the risk of lung cancer. Lung Cancer 2007 1.19
20 RGD peptides released from beta ig-h3, a TGF-beta-induced cell-adhesive molecule, mediate apoptosis. Oncogene 2003 1.19
21 Effect of polymer molecular weight on the tumor targeting characteristics of self-assembled glycol chitosan nanoparticles. J Control Release 2007 1.18
22 Erythropoietin decreases renal fibrosis in mice with ureteral obstruction: role of inhibiting TGF-beta-induced epithelial-to-mesenchymal transition. J Am Soc Nephrol 2007 1.18
23 Smart nanocarrier based on PEGylated hyaluronic acid for cancer therapy. ACS Nano 2011 1.18
24 Four novel RUNX2 mutations including a splice donor site result in the cleidocranial dysplasia phenotype. J Cell Physiol 2006 1.16
25 Tumor-targeting peptide conjugated pH-responsive micelles as a potential drug carrier for cancer therapy. Bioconjug Chem 2010 1.16
26 Molecular properties of wild-type and mutant betaIG-H3 proteins. Invest Ophthalmol Vis Sci 2002 1.14
27 Mechanism for phosphatidylserine-dependent erythrophagocytosis in mouse liver. Blood 2011 1.13
28 Self-assembled glycol chitosan nanoparticles for the sustained and prolonged delivery of antiangiogenic small peptide drugs in cancer therapy. Biomaterials 2008 1.12
29 Proteomic analysis of urinary exosomes from patients of early IgA nephropathy and thin basement membrane nephropathy. Proteomics 2011 1.11
30 Transforming growth factor-beta-inducible gene-h3 (beta(ig)-h3) promotes cell adhesion of human astrocytoma cells in vitro: implication of alpha6beta4 integrin. Neurosci Lett 2003 1.11
31 Targeting bladder tumor cells in vivo and in the urine with a peptide identified by phage display. Mol Cancer Res 2007 1.10
32 Stabilin-1 mediates phosphatidylserine-dependent clearance of cell corpses in alternatively activated macrophages. J Cell Sci 2009 1.10
33 The bone-related Zn finger transcription factor Osterix promotes proliferation of mesenchymal cells. Gene 2005 1.08
34 Beta ig-h3 mediates osteoblast adhesion and inhibits differentiation. Bone 2005 1.07
35 Polymorphisms of the DNA repair gene xeroderma pigmentosum group A and risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev 2002 1.07
36 Requirement of adaptor protein GULP during stabilin-2-mediated cell corpse engulfment. J Biol Chem 2008 1.05
37 Polymorphisms in TGF-beta1 gene and the risk of lung cancer. Lung Cancer 2006 1.05
38 Tumor specificity and therapeutic efficacy of photosensitizer-encapsulated glycol chitosan-based nanoparticles in tumor-bearing mice. Biomaterials 2009 1.05
39 Self-assembled nanoparticles based on glycol chitosan bearing 5beta-cholanic acid for RGD peptide delivery. J Control Release 2004 1.05
40 Discovery of a phosphatidylserine-recognizing peptide and its utility in molecular imaging of tumour apoptosis. J Cell Mol Med 2008 1.03
41 Tumoral acidic extracellular pH targeting of pH-responsive MPEG-poly(beta-amino ester) block copolymer micelles for cancer therapy. J Control Release 2007 1.03
42 Interleukin-18 stimulates fibronectin expression in primary human cardiac fibroblasts via PI3K-Akt-dependent NF-kappaB activation. J Cell Physiol 2008 1.03
43 Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel. J Control Release 2006 1.03
44 XPC polymorphisms and lung cancer risk. Int J Cancer 2005 1.03
45 Cross talk between engulfment receptors stabilin-2 and integrin αvβ5 orchestrates engulfment of phosphatidylserine-exposed erythrocytes. Mol Cell Biol 2012 1.02
46 Phage display selection of peptides that home to atherosclerotic plaques: IL-4 receptor as a candidate target in atherosclerosis. J Cell Mol Med 2008 1.01
47 Tumoral acidic pH-responsive MPEG-poly(beta-amino ester) polymeric micelles for cancer targeting therapy. J Control Release 2010 1.01
48 Expression of TGF-beta-induced matrix protein betaig-h3 is up-regulated in the diabetic rat kidney and human proximal tubular epithelial cells treated with high glucose. Kidney Int 2003 1.00
49 Epidermal growth factor-like domain repeat of stabilin-2 recognizes phosphatidylserine during cell corpse clearance. Mol Cell Biol 2008 1.00
50 Reverse signaling through BAFF differentially regulates the expression of inflammatory mediators and cytoskeletal movements in THP-1 cells. Immunol Cell Biol 2009 0.99
51 Polymorphisms in the CASPASE genes and survival in patients with early-stage non-small-cell lung cancer. J Clin Oncol 2009 0.99
52 Regulation of tumor angiogenesis by fastatin, the fourth FAS1 domain of betaig-h3, via alphavbeta3 integrin. Cancer Res 2005 0.99
53 Stabilin-2 is involved in lymphocyte adhesion to the hepatic sinusoidal endothelium via the interaction with alphaMbeta2 integrin. J Leukoc Biol 2007 0.99
54 A new atherosclerotic lesion probe based on hydrophobically modified chitosan nanoparticles functionalized by the atherosclerotic plaque targeted peptides. J Control Release 2008 0.98
55 TGF-beta1 enhances betaig-h3-mediated keratinocyte cell migration through the alpha3beta1 integrin and PI3K. J Cell Biochem 2004 0.97
56 HIF-1alpha controls keratinocyte proliferation by up-regulating p21(WAF1/Cip1). Biochim Biophys Acta 2007 0.97
57 -93G-->A polymorphism of hMLH1 and risk of primary lung cancer. Int J Cancer 2004 0.97
58 The COOH-terminal end of R-Ras alters the motility and morphology of breast epithelial cells through Rho/Rho-kinase. Cancer Res 2005 0.95
59 In vivo tumor targeting and radionuclide imaging with self-assembled nanoparticles: mechanisms, key factors, and their implications. Biomaterials 2007 0.94
60 Signalling pathway involving GULP, MAPK and Rac1 for SR-BI-induced phagocytosis of apoptotic cells. J Biochem 2009 0.94
61 Chimeric capsid protein as a nanocarrier for siRNA delivery: stability and cellular uptake of encapsulated siRNA. ACS Nano 2011 0.94
62 Heparin-deoxycholic acid chemical conjugate as an anticancer drug carrier and its antitumor activity. J Control Release 2006 0.94
63 Extracellular low pH modulates phosphatidylserine-dependent phagocytosis in macrophages by increasing stabilin-1 expression. J Biol Chem 2012 0.92
64 Physicochemical characterizations of self-assembled nanoparticles of glycol chitosan-deoxycholic acid conjugates. Biomacromolecules 2005 0.92
65 Detection of apoptosis in a rat model of focal cerebral ischemia using a homing peptide selected from in vivo phage display. J Control Release 2008 0.91
66 Methyl-CpG binding domain 1 gene polymorphisms and risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev 2005 0.90
67 Genetic variant in TP63 on locus 3q28 is associated with risk of lung adenocarcinoma among never-smoking females in Asia. Hum Genet 2012 0.90
68 In vivo imaging of tumor apoptosis using histone H1-targeting peptide. J Control Release 2010 0.89
69 Impact of low glucose degradation product bicarbonate/lactate-buffered dialysis solution on the epithelial-mesenchymal transition of peritoneum. Am J Nephrol 2009 0.89
70 Transforming growth factor β-induced protein promotes severe vascular inflammatory responses. Am J Respir Crit Care Med 2014 0.89
71 MEGF10 functions as a receptor for the uptake of amyloid-β. FEBS Lett 2010 0.88
72 Protein-phosphorylation-responsive polymeric nanoparticles for imaging protein kinase activities in single living cells. Angew Chem Int Ed Engl 2007 0.88
73 Antitumor effect of a transducible fusogenic peptide releasing multiple proapoptotic peptides by caspase-3. Mol Cancer Ther 2008 0.88
74 NF-kappaB activates fibronectin gene expression in rat hepatocytes. Biochem Biophys Res Commun 2002 0.88
75 Polymorphisms in apoptosis-related genes and survival of patients with early-stage non-small-cell lung cancer. Ann Surg Oncol 2010 0.88
76 Transforming growth factor-beta-induced gene product, as a novel ligand of integrin alphaMbeta2, promotes monocytes adhesion, migration and chemotaxis. Int J Biochem Cell Biol 2007 0.88
77 Lys751Gln polymorphism in the DNA repair gene XPD and risk of primary lung cancer. Lung Cancer 2002 0.87
78 Differential gene expression analysis using paraffin-embedded tissues after laser microdissection. J Cell Biochem 2003 0.87
79 A novel peptide probe for imaging and targeted delivery of liposomal doxorubicin to lung tumor. Mol Pharm 2011 0.86
80 Dialysis modality-dependent changes in serum metabolites: accumulation of inosine and hypoxanthine in patients on haemodialysis. Nephrol Dial Transplant 2010 0.86
81 No association between haplotypes of three variants (codon 81, 284, and 762) in poly(ADP-ribose) polymerase gene and risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev 2003 0.86
82 pH- and temperature-sensitive, injectable, biodegradable block copolymer hydrogels as carriers for paclitaxel. Int J Pharm 2006 0.86
83 Real time, high resolution video imaging of apoptosis in single cells with a polymeric nanoprobe. Bioconjug Chem 2011 0.86
84 Tumor endothelial cell targeted cyclic RGD-modified heparin derivative: inhibition of angiogenesis and tumor growth. Pharm Res 2008 0.85
85 Molecular targeting of atherosclerotic plaques by a stabilin-2-specific peptide ligand. J Control Release 2011 0.85
86 Enhanced antitumor effects by combination gene therapy using MDR1 gene shRNA and HSV1-tk in a xenograft mouse model. Cancer Lett 2009 0.85
87 Hypoxic activation of the atrial natriuretic peptide gene promoter through direct and indirect actions of hypoxia-inducible factor-1. Biochem J 2003 0.85
88 FAS1 domain protein inhibits VEGF165-induced angiogenesis by targeting the interaction between VEGFR-2 and αvβ3 integrin. Mol Cancer Res 2012 0.84
89 Designed nanocage displaying ligand-specific Peptide bunches for high affinity and biological activity. ACS Nano 2013 0.84
90 Relationship between XPG codon 1104 polymorphism and risk of primary lung cancer. Carcinogenesis 2003 0.84
91 Anterior segment dysgenesis after overexpression of transforming growth factor-beta-induced gene, beta igh3, in the mouse eye. Mol Vis 2007 0.84
92 Elevation of urinary betaig-h3, transforming growth factor-beta-induced protein in patients with type 2 diabetes and nephropathy. Diabetes Res Clin Pract 2004 0.84
93 Facilitated intracellular delivery of peptide-guided nanoparticles in tumor tissues. J Control Release 2011 0.84
94 Multiple FAS1 domains and the RGD motif of TGFBI act cooperatively to bind αvβ3 integrin, leading to anti-angiogenic and anti-tumor effects. Biochim Biophys Acta 2013 0.84
95 Adaptor protein GULP is involved in stabilin-1-mediated phagocytosis. Biochem Biophys Res Commun 2010 0.84
96 Induction of TGF-beta-inducible gene-h3 (betaig-h3) by TGF-beta1 in astrocytes: implications for astrocyte response to brain injury. Brain Res Mol Brain Res 2002 0.83
97 Thymosin beta4 is involved in stabilin-2-mediated apoptotic cell engulfment. FEBS Lett 2008 0.83
98 Effect of glucose degradation products on the peritoneal membrane in a chronic inflammatory infusion model of peritoneal dialysis in the rat. Perit Dial Int 2004 0.83
99 Conformational resemblance between the structures of integrin-activating pentapetides derived from betaig-h3 and RGD peptide analogues in a membrane environment. Peptides 2004 0.83
100 In situ dose amplification by apoptosis-targeted drug delivery. J Control Release 2011 0.82
101 Identification of polymorphisms in the XIAP gene and analysis of association with lung cancer risk in a Korean population. Cancer Genet Cytogenet 2008 0.82
102 TL1A induces the expression of TGF-β-inducible gene h3 (βig-h3) through PKC, PI3K, and ERK in THP-1 cells. Cell Immunol 2010 0.82
103 Effects of low glucose degradation products peritoneal dialysis fluid on the peritoneal fibrosis and vascularization in a chronic rat model. Ther Apher Dial 2007 0.82
104 Stabilin-2 mediates homophilic cell-cell interactions via its FAS1 domains. FEBS Lett 2009 0.82
105 Gas-generating polymeric microspheres for long-term and continuous in vivo ultrasound imaging. Biomaterials 2011 0.81
106 Endothelial argininosuccinate synthetase 1 regulates nitric oxide production and monocyte adhesion under static and laminar shear stress conditions. J Biol Chem 2010 0.81
107 Thrombin down-regulates the TGF-beta-mediated synthesis of collagen and fibronectin by human proximal tubule epithelial cells through the EPCR-dependent activation of PAR-1. J Cell Physiol 2010 0.81
108 Enhanced delivery of T cells to tumor after chemotherapy using membrane-anchored, apoptosis-targeted peptide. J Control Release 2012 0.81
109 A TGF-beta-induced gene, betaig-h3, is crucial for the apoptotic disappearance of the medial edge epithelium in palate fusion. J Cell Biochem 2009 0.81
110 Systemic delivery of siRNA by chimeric capsid protein: tumor targeting and RNAi activity in vivo. Mol Pharm 2012 0.81
111 The conserved histidine in epidermal growth factor-like domains of stabilin-2 modulates pH-dependent recognition of phosphatidylserine in apoptotic cells. Int J Biochem Cell Biol 2010 0.81
112 Low glucose degradation products dialysis solution modulates the levels of surrogate markers of peritoneal inflammation, integrity, and angiogenesis: preliminary report. Nephrology (Carlton) 2003 0.80
113 The attenuation of experimental lung metastasis by a bile acid acylated-heparin derivative. Biomaterials 2007 0.80
114 Proteomic identification of betaig-h3 as a lysophosphatidic acid-induced secreted protein of human mesenchymal stem cells: paracrine activation of A549 lung adenocarcinoma cells by betaig-h3. Mol Cell Proteomics 2011 0.80
115 In vivo imaging of myocardial cell death using a peptide probe and assessment of long-term heart function. J Control Release 2013 0.79
116 Antiangiogenic effect of bile acid acylated heparin derivative. Pharm Res 2006 0.79
117 Gene expression profile of human chondrocyte HCS-2/8 cell line by EST sequencing analysis. Gene 2004 0.79
118 The TGF-beta-induced gene product, betaig-h3: its biological implications in peritoneal dialysis. Nephrol Dial Transplant 2007 0.79
119 Combination therapy and noninvasive imaging with a dual therapeutic vector expressing MDR1 short hairpin RNA and a sodium iodide symporter. J Nucl Med 2008 0.79
120 TGF-beta-induced protein beta ig-h3 is upregulated by high glucose in vascular smooth muscle cells. J Cell Biochem 2003 0.79
121 Cyclosporin A suppresses prostate cancer cell growth through CaMKKβ/AMPK-mediated inhibition of mTORC1 signaling. Biochem Pharmacol 2012 0.79
122 SK&F 96365 induces apoptosis and autophagy by inhibiting Akt-mTOR signaling in A7r5 cells. Biochim Biophys Acta 2011 0.78
123 3,4-dideoxyglucosone-3-ene induces apoptosis in human peritoneal mesothelial cells. Perit Dial Int 2009 0.78
124 Polymeric nanoparticles for protein kinase activity. Chem Commun (Camb) 2007 0.78
125 Human sodium iodide symporter added to multidrug resistance 1 small hairpin RNA in a single gene construct enhances the therapeutic effects of radioiodine in a nude mouse model of multidrug resistant colon cancer. Cancer Biother Radiopharm 2010 0.77
126 A novel method of ligand peptidomics to identify peptide ligands binding to AQP2-expressing plasma membranes and intracellular vesicles of rat kidney. Am J Physiol Renal Physiol 2008 0.77
127 An apoptosis-homing peptide-conjugated low molecular weight heparin-taurocholate conjugate with antitumor properties. Biomaterials 2012 0.77
128 Identification of a peptide ligand recognizing dysfunctional endothelial cells for targeting atherosclerosis. J Control Release 2008 0.77
129 Apoptosis imaging studies in various animal models using radio-iodinated peptide. Apoptosis 2015 0.77
130 Combination gene therapy using multidrug resistance (MDR1) gene shRNA and herpes simplex virus-thymidine kinase. Cancer Lett 2007 0.77
131 Expression patterns of betaig-h3 in chondrocyte differentiation during endochondral ossification. Exp Mol Med 2008 0.76
132 Molecular imaging of cell death in an experimental model of Parkinson's disease with a novel apoptosis-targeting peptide. Mol Imaging Biol 2012 0.76
133 Aquaporin 3 expression is up-regulated by TGF-β1 in rat peritoneal mesothelial cells and plays a role in wound healing. Am J Pathol 2012 0.76
134 Small heat shock protein as a multifunctional scaffold: integrated tumor targeting and caspase imaging within a single cage. Biomacromolecules 2011 0.76
135 Combination therapy of heparin-deoxycholic acid conjugate and doxorubicin against squamous cell carcinoma and B16F10 melanoma. Pharm Res 2007 0.76
136 CD36 is required for myoblast fusion during myogenic differentiation. Biochem Biophys Res Commun 2012 0.76
137 Stabilin-2 acts as an engulfment receptor for the phosphatidylserine-dependent clearance of primary necrotic cells. Biochem Biophys Res Commun 2013 0.76
138 Tgfbi deficiency leads to a reduction in skeletal size and degradation of the bone matrix. Calcif Tissue Int 2014 0.75
139 Identification of macrophage genes responsive to extracellular acidification. Inflamm Res 2013 0.75
140 T-CAM, a fastatin-FIII 9-10 fusion protein, potently enhances anti-angiogenic and anti-tumor activity via alphavbeta3 and alpha5beta1 integrins. Exp Mol Med 2008 0.75
141 Synthesis and evaluation of a radioiodinated bladder cancer specific peptide. Bioorg Med Chem 2012 0.75
142 Backbone 1H, 15N, and 13C resonance assignments of the repeated domain of human beta ig-h3 protein. J Biomol NMR 2002 0.75
143 Corrigendum: Functional transformations of bile acid transporters induced by high-affinity macromolecules. Sci Rep 2015 0.75